FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer

PURPOSE: Therapy response to neoadjuvant radiochemotherapy (nRCT) of locally advanced rectal cancer varies widely so that markers predicting response are urgently needed. Fibroblast growth factor (FGF) and FGF receptor (FGFR) signaling is involved in pro-survival signaling and thereby may result in...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer Res Clin Oncol
Auteurs principaux: Harpain, Felix, Ahmed, Mohamed A., Hudec, Xenia, Timelthaler, Gerald, Jomrich, Gerd, Müllauer, Leonhard, Selzer, Edgar, Dörr, Wolfgang, Bergmann, Michael, Holzmann, Klaus, Grasl-Kraupp, Bettina, Grusch, Michael, Berger, Walter, Marian, Brigitte, Silberhumer, Gerd R.
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2018
Sujets:
Original Article – Cancer Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6326005/
https://ncbi.nlm.nih.gov/pubmed/30276721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-018-2757-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires